Deborah Crouch

Array ( [id] => 8782278 [patent_doc_number] => 20130104253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'CYTOPLASMIC TRANSFER TO DE-DIFFERENTIATE RECIPIENT CELLS' [patent_app_type] => utility [patent_app_number] => 13/617988 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6817 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13617988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8684359 [patent_doc_number] => 20130052643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'METHOD FOR GENERATING NUCLEAR REPROGRAMMED CELL, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/597854 [patent_app_country] => US [patent_app_date] => 2012-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10419 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566011 [patent_doc_number] => 20120328582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Primate Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 13/595587 [patent_app_country] => US [patent_app_date] => 2012-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10028 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707511 [patent_doc_number] => 20130064800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair' [patent_app_type] => utility [patent_app_number] => 13/571494 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13014 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13571494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431589 [patent_doc_number] => 20120253463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METHODS OF GENERATING A TENDON TISSUE' [patent_app_type] => utility [patent_app_number] => 13/526633 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22648 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359080 [patent_doc_number] => 20120214232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHODS OF CULTURING CELLS IN A MEDIUM COMPRISING TRANSFORMING GROWTH FACTOR BETA 1 AND BASIC FIBROBLAST GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 13/466161 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15454 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476735 [patent_doc_number] => 20120276142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IGE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/466015 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23108 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11790184 [patent_doc_number] => 09399758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'SSEA3(+) pluripotent stem cell that can be isolated from body tissue' [patent_app_type] => utility [patent_app_number] => 13/435703 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 28765 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289833 [patent_doc_number] => 20120178161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/427548 [patent_app_country] => US [patent_app_date] => 2012-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13664 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834355 [patent_doc_number] => 08450110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Human neuronal progenitor cells co-expressing nestin and Pax6, and co-expressing NeuN or Tuj1' [patent_app_type] => utility [patent_app_number] => 13/425235 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13506 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834355 [patent_doc_number] => 08450110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Human neuronal progenitor cells co-expressing nestin and Pax6, and co-expressing NeuN or Tuj1' [patent_app_type] => utility [patent_app_number] => 13/425235 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13506 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405418 [patent_doc_number] => 20120237481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Incorporation of the B18R gene to enhance antitumor effect of virotherapy' [patent_app_type] => utility [patent_app_number] => 13/420734 [patent_app_country] => US [patent_app_date] => 2012-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4718 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239810 [patent_doc_number] => 20120148551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MARROW STEM CELL AND PANCREATIC BETA CELL FUSION CELL USEFUL FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 13/399750 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5766 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8569471 [patent_doc_number] => RE043876 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-12-25 [patent_title] => 'Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm' [patent_app_type] => reissue [patent_app_number] => 13/372641 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 39 [patent_no_of_words] => 22207 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335082 [patent_doc_number] => 20120201792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHODS AND PRODUCTS FOR MANIPULATING HEMATOPOIETIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/363289 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22027 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13363289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870107 [patent_doc_number] => 08895301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Exogenous Pax6 nucleic acid expression in primate neural stem cells maintains proliferation without differentiation' [patent_app_type] => utility [patent_app_number] => 13/360326 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 22 [patent_no_of_words] => 14391 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9996173 [patent_doc_number] => 09040771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder' [patent_app_type] => utility [patent_app_number] => 13/360344 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 8196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9271315 [patent_doc_number] => 20140026233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'TRANSGENIC PIG EXPRESSING STNFR1-FC GENES AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/980846 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9042 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759874 [patent_doc_number] => 08420393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension' [patent_app_type] => utility [patent_app_number] => 13/352252 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 17 [patent_no_of_words] => 47842 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352252 [rel_patent_id] =>[rel_patent_doc_number] =>)